New Breast Cancer Research from SABCS

SABCS New Breast Cancer Research

New Breast CancerThe San Antonio Breast Cancer Symposium happens once every year. It’s designed to provide new, state-of-the-art breast cancer research information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease.

This information is presented to the breast cancer community. An international audience comprised of academic and private physicians, researchers, advocacy groups, patients and survivors are all in attendance at SABCS to find out about the latest in breast cancer research.

Europa Donna Breast Cancer Advocate & Alamo Breast Cancer Scholarship recipient Sema Erdem shares new breast cancer research findings from SABCS.

This video has been brought to you by: The Alamo Breast Cancer Foundation


Sema Erdem:  The most impressive outcome or the highlight of this conference this year was the immunotherapy part.  I was always thinking the preventive for active management, but on the other hand during the treatment cycle of breast cancer having the information that immunotherapy is implemented and outcome of the clinical trials being shared with us that’s really impressive and the patient-centric, patient-targeted therapies, personalized medicine, and some of the outstanding issues where the patient advocates could contribute gave the insight that we have a lot of work to do and we have to be very scheduled because it’s a tight schedule for all of us. 

We don’t want this to be a threat for a woman within a very short time, very short time we are referring to five years or four years whatever is the time, we have to speed up our activities and do our best as patient advocates.  I think we are highlighted with the idea of immunotherapy and personalized medicine and the lack of sharing data or data processing in a more, more efficient way like big data processing integrating information technology facilities to clinical trials in cancer research and taking our responsibilities as patient advocates would be the most challenging outcome of SABC and a personal target goal for myself to be shared on the way back home with the European colleagues.  Thank you very much for this nice interview and all the appreciations to the team who organized this excellent San Antonio Breast Cancer Conference and to Alamo.